Moreover, we first showed that adding u[TIMP-2]*[IGFBP7] to the clinical risk factor model, alone or combined with renal injury biomarkers, significantly improved the risk classification of AKI progression and AKI progression with death in sepsis, as evidenced by significant NRI and IDI. The gene discussed is IGFBP7; the disease is acute kidney injury.